Tagged with Hot Topics

Hot Topics in Spanish Pharma 2022

Spain Hot Topics in Spanish Pharma 2022

Spain Over the course of 2022, PharmaBoardroom spoke to over 50 leading stakeholders in the Spanish healthcare and life sciences, from top Spanish scientists to regional ministers of health, multinational affiliate managers, and the heads of some of the country’s leading domestic firms. These interviewees’ insights are catalogued in the downloadable…

Hot Topics in Moroccan Pharma

Morocco Hot Topics in Moroccan Pharma

Morocco In 2020, PharmaBoardroom has met with stakeholders from across the Moroccan healthcare and life sciences industries. These interviewees range from general managers overseeing several countries in the region from a base in Morocco to association heads and key opinion leaders from the worlds of academia and policymaking. Several recurring themes…

Hot Topics in Belgian Pharma

Belgium Hot Topics in Belgian Pharma

Belgium In 2020 PharmaBoardroom sat down with several key stakeholders in Belgian pharma to discuss company strategy, the Belgian healthcare landscape at large, and the country’s role within the wider European and global ecosystem. Here we highlight some of the key themes of the discussions: innovation, generics and biosimilars, and teamwork.…

Hot Topics in Mexican Pharma

Mexico Hot Topics in Mexican Pharma

Mexico Earlier in 2020, PharmaBoardroom sat down with several key stakeholders in the Mexican healthcare and life sciences industry, from the leaders of multinational affiliates, start-up entrepreneurs, association heads, and key opinion leaders. Here, we round up three of their most talked about topics. Government One of the most talked-about…

Hot Topics in Chinese Biotech

China Hot Topics in Chinese Biotech

China PharmaBoardroom sat down with more than 25 biotech CEOs in China in 2019. We analyzed the contents of the interviews and found the following recurring themes at the top of these executives’ minds. “Patients” One recurring theme throughout the interviews was a stated commitment to patients. Many of these…

Other Topics

India

M&A

European Biotech

Cell & Gene Therapy

R&D Section Page